OUTCOME OF INTERSTITIAL LUNG DISEASE (ILD) IN ANTI-PM/SCL PATIENTS WITH SYSTEMIC SCLEROSIS: RESULTS FROM AN EUSTAR CASE-CONTROL STUDY.

被引：0
|
作者：
Lazzaroni, M. G. [1 ]
Campochiaro, C. [2 ,3 ,4 ]
Marasco, E. [5 ]
De Vries-Bouwstra, J. [6 ]
Franceschini, F. [1 ]
Del Galdo, F. [7 ]
Denton, C. [3 ,4 ]
Cavagna, L. [5 ]
Distler, O. [8 ]
Allanore, Y. [9 ,10 ]
Airo, P. [1 ]
机构：
[1] Univ Brescia, ASST Spedali Civili Brescia, Brescia, Italy
[2] Ist Sci San Raffaele, Milan, Italy
[3] Royal Free Hosp, London, England
[4] UCL, Med Sch, London, England
[5] Univ Pavia, Hosp IRCCS Policlin S Matteo Fdn Pavia, Pavia, Italy
[6] Leiden Univ Med Ctr LUMC, Leiden, Netherlands
[7] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England
[8] Univ Hosp Zurich, Zurich, Switzerland
[9] Univ Paris 05, Paris, France
[10] Cochin Hosp, Paris, France
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.4890
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0328
引用
收藏
页码：1105 / 1106
页数：2
相关论文
共 50 条
  • [31] RESULTS OF LONG-TERM (36 MONTHS) USE OF RITUXIMAB (RTM) AND IMMUNOSUPPRESSANTS (IS) IN PATIENTS WITH SYSTEMIC SCLEROSIS (SSC) WITH INTERSTITIAL LUNG DISEASE (ILD)
    Koneva, Olga
    Garzanova, Liudmila
    Ovsynnikova, Olga
    Desinova, Oxana
    Ananyeva, Lidia
    Shayakhmetova, Rushana
    Starovoytova, Mayya
    Glukhova, Svetlana I.
    CHEST, 2022, 162 (04) : 2181A - 2182A
  • [32] Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis:: a European EUSTAR-initiated multi-centre case-control study
    Rozman, B.
    Cucnik, S.
    Sodin-Semrl, S.
    Czirjak, L.
    Varju, C.
    Distler, O.
    Huscher, D.
    Aringer, M.
    Steiner, G.
    Matucci-Cerinic, M.
    Guiducci, S.
    Stamenkovic, B.
    Stankovic, A.
    Kveder, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (09) : 1282 - 1286
  • [33] Idiopathic Parkinson's disease and diabetes: Results from a case-control study.
    D'Amelio, Marco
    Ragonese, Paolo
    Callari, Graziella M. D.
    Palmeri, Barbara M. D.
    Di Benedetto, Norma
    Aridon, Paolo
    Salemi, Giuseppe
    Savettieri, Giovanni
    NEUROLOGY, 2007, 68 (12) : A257 - A257
  • [34] Treatment with nintedanib is as effective and safe in patients with other connective tissue diseases (CTDs)-interstitial lung disease (ILD) as in patients with systemic sclerosis-ILD: A multicenter retrospective study
    Misirci, Salim
    Ekin, Ali
    Yagiz, Burcu
    Coskun, Belkis Nihan
    Basibuyuk, Fatma
    Birlik, Ahmet Merih
    Sari, Ismail
    Karaca, Aylin Dolu
    Koca, Suleyman Serdar
    Cetin, Gozde Yildirim
    Okyar, Burak
    Atilla, Nurhan
    Dalkilic, Ediz
    Pehlivan, Yavuz
    CLINICAL RHEUMATOLOGY, 2025, 44 (03) : 1187 - 1195
  • [35] Safety and tolerability of pirfenidone (PFD) in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD)-The LOTUSS study
    Khanna, Dinesh
    Albera, Carlo
    Fischer, Aryeh
    Seibold, James
    Raghu, Ganesh
    Khalidi, Nader
    Chung, Lorinda
    Schiopu, Elena
    Chen, Dan
    Gorina, Eduard
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [36] Efficacy and Safety of Riociguat in Patients with Early Diffuse Cutaneous Systemic Sclerosis and Interstitial Lung Disease (SSc-ILD): Results from the Phase IIb RISE-SSc Study
    Distler, O.
    Allanore, Y.
    Denton, C.
    Kuwana, M.
    Matucci-Cerinic, M.
    Pope, J. E.
    Pena, J. de Oliveira
    Laapas, K.
    Yao, Z.
    Behmenburg, F.
    Hemmrich, M.
    Khanna, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [37] EFFICACY AND SAFETY OF RIOCIGUAT IN PATIENTS WITH EARLY DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS AND INTERSTITIAL LUNG DISEASE (SSC-ILD): RESULTS FROM THE PHASE IIB RISE-SSC STUDY
    Distler, Oliver
    Allanore, Yannick
    Denton, Christopher
    Kuwana, Masataka
    Matucci-Cerinic, Marco
    Pope, Janet
    Pena, Janethe de Oliveria
    Laapas, Kaisa
    Yao, Zhen
    Behmenburg, Friederike
    Hemmrich, Melanie
    Khanna, Dinesh
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 167 - 167
  • [38] Examining Clinical Characteristics of Patients with Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) and Myositis Antibodies: A Retrospective Case Series
    Pandya, K.
    Raddawi, M.
    D'Silva, K. M.
    Montesi, S. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [39] Anti-fibroblast antibodies from systemic sclerosis patients bind to α-enolase and are associated with interstitial lung disease
    Terrier, Benjamin
    Tamby, Mathieu C.
    Camoin, Luc
    Guilpain, Philippe
    Berezne, Alice
    Tamas, Nicolas
    Broussard, Cedric
    Hotellier, Francoise
    Humbert, Marc
    Simonneau, Gerald
    Guillevin, Loic
    Mouthon, Luc
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S836 - S836
  • [40] Serum Metabolomic Profiling in Rheumatoid Arthritis Patients With Interstitial Lung Disease: A Case-Control Study
    Furukawa, Hiroshi
    Oka, Shomi
    Shimada, Kota
    Okamoto, Akira
    Hashimoto, Atsushi
    Komiya, Akiko
    Saisho, Koichiro
    Yoshikawa, Norie
    Katayama, Masao
    Matsui, Toshihiro
    Fukui, Naoshi
    Migita, Kiyoshi
    Tohma, Shigeto
    FRONTIERS IN MEDICINE, 2020, 7
12345